Access Keys:
Skip to content (Access Key - 0)

Center for Cancer Research National Cancer Institute
NCI Drug Development Collaborative

Useful Abbreviations

CAPR

NCI Center for Advanced Preclinical Research-CCR

CBC

Chemical Biology Consortium

CCR

Center for Cancer Research-NCI

CDA

Confidential Disclosure Agreement

CRADA

Cooperative Research and Development Agreement

CSBF

Chemical and Structural Biology Faculty-CCR

CTAG

Clinical Translational Advisory Group

CTEP

Cancer Therapy Evaluation Program

DCTD

Division of Cancer Treatment and Diagnosis- NCI

DDCDrug Development Colloborative-CCR and DCTD (formerly MTF)

DDG

Drug Development Group-DCTD

DTP

Developmental Therapeutics Program-DCTD

EIR

Employee Invention Report

IND

Investigational new drug

IP

Intellectual property

IRB

Institutional review board

IRP

Intramural Research Program

JDC

Joint Development Committee (DCTD and CCR)

MMHCC

Mouse Model of Human Cancers Consortium

MTA

Material Transfer Agreement

MTL

Molecular Targets Laboratory-CCR

MTF

Molecular Targets Faculty-CCR

NCI

National Cancer Institute

NExT

NCI Experimental Therapeutics Program-DCTD and CCR

OGC

Office of the General Counsel

OTT

Office of technology transfer-NIH

PD

Pharmacodynamic

PK

Pharmacokinetic

RAID

Rapid Access to Intervention Development-DCTD

RAND

Rapid Access to NCI Discovery Resources-DCTD

RRS

Resource request system

TTB

Technology transfer branch-NCI

UBMTA

Master Agreement among the NIH, universities, and other non-profit research facilities used to expedite transfer of research materials among non-commercial entities



[Previous page] | [Next Page]

Added by Boersma, Brenda (NIH/NCI) [E] , last edited by Boersma, Brenda (NIH/NCI) [E] on Mar 25, 2013 10:33